How long does it take to achieve the full effectiveness of Addyi (flibanserin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Time to Achieve Full Effectiveness of Addyi (Flibanserin)

Flibanserin (Addyi) reaches its full effectiveness after approximately 4 weeks (28 days) of daily use. 1

Pharmacokinetic Timeline

  • Flibanserin reaches steady state plasma concentration after 3 days of consistent daily dosing 1
  • Despite reaching steady state quickly, the clinical effects on sexual desire take longer to manifest 2
  • The medication has a mean terminal half-life of approximately 11 hours, requiring daily dosing for maintained effectiveness 1

Clinical Response Timeline

  • Unlike stimulant medications that show immediate effects, flibanserin requires consistent daily use for several weeks before patients experience the full therapeutic benefit 2
  • Meta-analyses of clinical trials show that the full effects on sexual desire and function typically become apparent after 4 weeks of continuous use 3
  • The medication should be taken daily at bedtime to minimize side effects like somnolence and dizziness while maintaining efficacy 1

Important Monitoring Considerations

  • Patients should be evaluated for treatment response after 8 weeks of therapy 3
  • If no improvement in sexual desire is noted after 8 weeks of continuous treatment, the medication should be discontinued 4
  • Monitoring for adverse effects should be conducted throughout the initial weeks of treatment, with particular attention to hypotension, syncope, and CNS depression 1

Factors That May Affect Time to Response

  • Hepatic function can significantly impact flibanserin metabolism, with impaired liver function increasing drug exposure 4.5-fold and extending the half-life to 26 hours 1
  • CYP2C19 poor metabolizers may experience higher drug concentrations and potentially faster onset of effects, but also increased risk of adverse events 1
  • Concurrent use of alcohol or CYP3A4 inhibitors can alter the medication's effectiveness timeline and increase risk of adverse effects 1

Efficacy Expectations

  • Clinical trials demonstrated modest benefits with flibanserin, resulting in approximately one additional satisfying sexual event every two months compared to placebo 5
  • Patients should be counseled about realistic expectations regarding the medication's effects and the timeframe for improvement 3, 4
  • Unlike medications for erectile dysfunction that work on demand, flibanserin requires continuous daily dosing to maintain its therapeutic effect 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Efficacy and safety of flibanserin "new female Viagra®?": Literature review].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2016

Research

Flibanserin and its discontents.

Archives of women's mental health, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.